Reaction Details Report a problem with these data
Target
AP-4 complex subunit sigma-1
Ligand
BDBM484103
Substrate
n/a
Meas. Tech.
Human Sigma-1 Receptor Radioligand Assay
Ki
<100±n/a nM
Citation
 Virgili-Bernado, M; Almansa-Rosales, C; Alegret-Molina, C Oxadiazaspiro compounds for the treatment of drug abuse and addiction US Patent  US10927128 Publication Date 2/23/2021 
Target
Name:
AP-4 complex subunit sigma-1
Synonyms:
AP-4 complex subunit sigma-1 | AP4S1 | AP4S1_HUMAN | Sigma-1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
17000.04
Organism:
Homo sapiens (Human)
Description:
Sigma-1 0 HUMAN::Q9Y587
Residue:
144
Sequence:
MIKFFLMVNKQGQTRLSKYYEHVDINKRTLLETEVIKSCLSRSNEQCSFIEYKDFKLIYRQYAALFIVVGVNDTENEMAIYEFIHNFVEVLDEYFSRVSELDIMFNLDKVHIILDEMVLNGCIVETNRARILAPLLILDKMSES
  
Inhibitor
Name:
BDBM484103
Synonyms:
8-(3,4-difluorobenzyl)-12-ethyl-4-oxa-8,12- diazadispiro[2.1.5.3]tridecan-13-one | US10927128, Example 24
Type:
Small organic molecule
Emp. Form.:
C19H24F2N2O2
Mol. Mass.:
350.4029
SMILES:
CCN1CC2(CCN(Cc3ccc(F)c(F)c3)CC2)OC2(CC2)C1=O
Structure:
Search PDB for entries with ligand similarity: